These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 2786907)
1. Stable association of processed antigen with antigen-presenting cell membranes. Jensen PE J Immunol; 1989 Jul; 143(2):420-5. PubMed ID: 2786907 [TBL] [Abstract][Full Text] [Related]
2. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells. Snider DP; Segal DM J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743 [TBL] [Abstract][Full Text] [Related]
3. Characterization of antigen processing and presentation by resting B lymphocytes. Gosselin EJ; Tony HP; Parker DC J Immunol; 1988 Mar; 140(5):1408-13. PubMed ID: 3257975 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes. Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762 [TBL] [Abstract][Full Text] [Related]
5. Time dependence of B cell processing and presentation of peptide and native protein antigens. Lakey EK; Casten LA; Niebling WL; Margoliash E; Pierce SK J Immunol; 1988 May; 140(10):3309-14. PubMed ID: 2834435 [TBL] [Abstract][Full Text] [Related]
6. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation. Dang LH; Lien LL; Benacerraf B; Rock KL J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833 [TBL] [Abstract][Full Text] [Related]
7. Kinetics of MHC-antigen complex formation on antigen-presenting cells. Roosnek E; Demotz S; Corradin G; Lanzavecchia A J Immunol; 1988 Jun; 140(12):4079-82. PubMed ID: 2453565 [TBL] [Abstract][Full Text] [Related]
8. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain. Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208 [TBL] [Abstract][Full Text] [Related]
9. Processing and presentation of insulin. II. Evidence for intracellular, plasma membrane-associated and extracellular degradation of human insulin by antigen-presenting B cells. Semple JW; Ellis J; Delovitch TL J Immunol; 1989 Jun; 142(12):4184-93. PubMed ID: 2656861 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme. Demotz S; Grey HM; Appella E; Sette A Nature; 1989 Dec; 342(6250):682-4. PubMed ID: 2480524 [TBL] [Abstract][Full Text] [Related]
11. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes. Prina E; Jouanne C; de Souza Lão S; Szabo A; Guillet JG; Antoine JC J Immunol; 1993 Aug; 151(4):2050-61. PubMed ID: 8102156 [TBL] [Abstract][Full Text] [Related]
12. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells. Adorini L; Guéry JC; Fuchs S; Ortiz-Navarrete V; Hämmerling GJ; Momburg F J Immunol; 1993 Oct; 151(7):3576-86. PubMed ID: 7690807 [TBL] [Abstract][Full Text] [Related]
13. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines. Whalen BJ; Tony HP; Parker DC J Immunol; 1988 Oct; 141(7):2230-9. PubMed ID: 2971722 [TBL] [Abstract][Full Text] [Related]
15. Inefficient peptide binding by cell-surface class II MHC molecules. Sherman MA; Weber DA; Spotts EA; Moore JC; Jensen PE Cell Immunol; 1997 Nov; 182(1):1-11. PubMed ID: 9427804 [TBL] [Abstract][Full Text] [Related]
16. Probing the structure of processed antigen by using biotin and avidin. MHC-dependent inhibition of responses to selected biotinyl-insulin derivatives. Jensen PE; Wilkinson KD J Immunol; 1989 Dec; 143(11):3423-9. PubMed ID: 2685118 [TBL] [Abstract][Full Text] [Related]
17. Effect of gamma radiation on resting B lymphocytes. II. Functional characterization of the antigen-presentation defect. Ashwell JD; Jenkins MK; Schwartz RH J Immunol; 1988 Oct; 141(8):2536-44. PubMed ID: 2844902 [TBL] [Abstract][Full Text] [Related]
18. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell. Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420 [TBL] [Abstract][Full Text] [Related]
19. Rafting MHC-II domains in the APC (presynaptic) plasma membrane and the thresholds for T-cell activation and immunological synapse formation. Gombos I; Detre C; Vámosi G; Matkó J Immunol Lett; 2004 Mar; 92(1-2):117-24. PubMed ID: 15081535 [TBL] [Abstract][Full Text] [Related]
20. Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin. Diment S J Immunol; 1990 Jul; 145(2):417-22. PubMed ID: 1694878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]